top of page

Key Features

  • Rapid screening with interpretable reports

  • Annular sizing and access route analysis

  • IFU-based or customizable criteria

TTVR (REC)

  • Regulatory: Research Only

  • Clinical Applications: Tricuspid Regurgitation

  • Modality: CT

Latest News

Press Release: LARALAB GmbH Launches Groundbreaking New Product 'REC - Rapid Eligibility Check'.

13th May, 2024

Peer-Reviewed Publications

bottom of page